Bone Therapeutics SA [BOTHE] vs SD Worx SA [BE0002655364] Detailed Stock Comparison
TLDR: Quick Comparison Summary
We found some data (2 metrics), but not enough for a complete comparison. Metrics like P/E ratio, profitability, and financial health are still available in the detailed tabs below.
View Metrics Details
Vital Metrics Comparison
Note: Limited metrics are available for comparison. Check other tabs for more detailed analysis.
| Metric | Bone Therapeutics SA | SD Worx SA | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 0.00 | N/A | N/A |
| Debt-to-Equity Ratio | -0.25 | N/A | N/A |
| EV/EBITDA | -0.96 | N/A | N/A |
| Return on Equity | 16.88% | N/A | N/A |
| Return on Assets (TTM) | -65.37% | N/A | N/A |
| 1-Year Return | -80.00% | -0.18% | SD Worx SA |
| Price-to-Sales Ratio (TTM) | 0.00 | N/A | N/A |
| Enterprise Value | $11.29M | $0 | Bone Therapeutics SA |
| EV/Revenue Ratio | 11.29 | N/A | N/A |
| Revenue per Share (TTM) | $0 | N/A | N/A |
| Earnings per Share (Diluted) | $-0.77 | N/A | N/A |
Bone Therapeutics SA vs SD Worx SA Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Bone Therapeutics SA | -9.09% | N/A | N/A | N/A | N/A | N/A |
| SD Worx SA | 0.00% | 0.08% | 0.08% | 0.06% | 0.16% | 0.27% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Bone Therapeutics SA | -80.00% | -98.25% | -99.73% | -99.95% | -99.95% | -99.95% |
| SD Worx SA | -0.18% | 0.45% | -3.51% | -3.51% | -3.51% | -3.51% |
Performance & Financial Health Analysis: Bone Therapeutics SA vs SD Worx SA
| Metric | BOTHE | BE0002655364 |
|---|---|---|
| Market Information | ||
| Market Cap | €0 | €0 |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 412,017 | 16,205 |
| 90 Day Avg. Volume | 174,005 | 20,238 |
| Last Close | €0.00 | €100.34 |
| 52 Week Range | €0.00 - €0.00 | €99.83 - €100.85 |
| % from 52W High | -37.50% | -0.51% |
| All-Time High | €28.90 (Feb 09, 2015) | €104.50 (Jan 31, 2022) |
| % from All-Time High | N/A | -3.98% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | N/A |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | N/A | N/A |
| Operating Margin (TTM) | N/A | N/A |
| Return on Equity (TTM) | 0.17% | N/A |
| Debt to Equity (MRQ) | -0.25 | N/A |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | N/A | N/A |
| Cash per Share (MRQ) | N/A | N/A |
| Operating Cash Flow (TTM) | €-14,067,000 | €0 |
| Levered Free Cash Flow (TTM) | €-12,925,000 | €0 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Bone Therapeutics SA vs SD Worx SA
| Metric | BOTHE (Apr 10, 2026) | BE0002655364 (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 0.00 | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| Price to Sales (TTM) | 0.00 | N/A |
| Price to Book (MRQ) | N/A | N/A |
| Market Capitalization | ||
| Market Capitalization | €0 | €0 |
| Enterprise Value | €11.29M | €0 |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 11.29 | N/A |
| Enterprise to EBITDA | -0.96 | N/A |
| Risk & Other Metrics | ||
| Beta | N/A | N/A |
| Book Value per Share (MRQ) | N/A | N/A |
Financial Statements Comparison: Bone Therapeutics SA vs SD Worx SA
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | BOTHE | BE0002655364 |
|---|---|---|
| Revenue/Sales | N/A | N/A |
| Cost of Goods Sold | N/A | N/A |
| COGS % of Revenue | - | - |
| Gross Profit | N/A | N/A |
| Gross Margin | - | - |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| Operating Margin | - | - |
| EBITDA | N/A | N/A |
| EBITDA Margin | - | - |
| Pre-Tax Income | N/A | N/A |
| Pre-Tax Income % of Revenue | - | - |
| Income Tax | N/A | N/A |
| Income Tax % of Revenue | - | - |
| Net Income (Profit) | N/A | N/A |
| Profit Margin | - | - |
Balance Sheet & Liquidity Metrics
| Metric | BOTHE | BE0002655364 |
|---|---|---|
| Cash & Equivalents | N/A | N/A |
| Total Current Assets | N/A | N/A |
| Total Current Assets % of Revenue | - | - |
| Total Current Liabilities | N/A | N/A |
| Total Current Liabilities % of Revenue | - | - |
| Long-Term Debt | N/A | N/A |
| Long-Term Debt % of Revenue | - | - |
| Total Shareholders Equity | N/A | N/A |
| Retained Earnings | N/A | N/A |
| Retained Earnings % of Revenue | - | - |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison
| Metric | BOTHE | BE0002655364 |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Operating Cash Flow % of Revenue | - | - |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| FCF Margin | - | - |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | BOTHE | BE0002655364 |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 16.86M | N/A |
| Float Shares | N/A | N/A |
| % Held by Insiders | N/A | N/A |
| % Held by Institutions | N/A | N/A |
| % Held by Public | N/A | N/A |
Dividend Analysis & Yield Comparison: Bone Therapeutics SA vs SD Worx SA
| Metric | BOTHE | BE0002655364 |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |